Exstent exhibited at EACTS 2025 in Copenhagen, Denmark, which took place between 8 and 11 October 2025.
The Exstent team was represented by Founder and Technical Director Tal Golesworthy, Clinical Business Development Manager Andrew Westmacott and ExoVasc® surgeon Ludek Pavel.
Andrew Westmacott commented: “The meeting was an excellent opportunity to interact with surgeons, distributors both current and prospective and industry colleagues. We had some great conversations which we are looking forward to continuing.”
Aortic PEARS was also the subject of four presentations or papers at the meeting. This included an abstract from Senior Fellow Ana Redondo called “10 years of Ross-PEARS: Preliminary experience in 100 cases”, which won the EACTS Presidents Choice Award for the top abstract in the congenital field.
